OSE Immunotherapeutics announces H1 2021 results and provides a corporate update

Latest Posts

EMA accepts filing of marketing authorization application for Valneva’s inactivated COVID-19 vaccine candidate

23 May 2022

Valneva, a specialty vaccine company, confirmed that the European Medicines Agency (“EMA”) has accepted the filing of a marketing authorization... View Article

Promega and Stilla announce co-marketing agreement to offer complete digital PCR workflow solution

18 May 2022

Promega Corporation – member of Atlanpole Biotherapies and leader in providing innovative solutions and technical support to the life sciences industry, and... View Article

ALGOSOURCE announces the recruitment of the first patient in the PROPERTY clinical trial for the PHYCOCARE® product and accelerates its clinical nutraceutical program to support digestive cancer therapies

13 May 2022

The world’s first clinical nutraceutical program based on microalgae A breakthrough innovation in the therapeutic management of digestive cancers The... View Article

« Previous 1 … 17 18 19 20 21 … 160 Next »